Efficacy, Immunogenicity and Safety of adjuvanted Herpes Zoster-Virus Subunit Vaccine Candidates in Adults from 60 Years and older: Results from the Efficacy Studies ZOE-50 and ZOE-70
Por:
McElhaney, J, Lal, H, Cunningham, A, Levin, M, Chlibek, R, Diez-Domingo, J, Athan, E, Berglund, J, Downey, J, Ghesquiere, W, Godeaux, O, Gorfinkel, I, Hwang, S, Korhonen, T, McNeil, S, Pauksens, K, Puig-Barbera, J, Avelino-Silva, T, Vesikari, T, Volpi, A, Watanabe, D, Yeo, W, Campora, L, Vanden Abeele, C, Oostvogels, L, Heinemann, T and Hain, J
Publicada:
1 abr 2018
Categoría:
Internal medicine
Resumen:
|